CEGIR Grant Renewed for $7.5M Over 5 years

Post Date: October 7, 2019


Marc Rothenberg, MD, PhD, Director of the Cincinnati Center for Eosinophilic Disorders, will continue leading the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) along with  Glenn Furuta, MD, director of the Gastrointestinal Eosinophilic Diseases Program at Children’s Hospital Colorado.

Read News Release

CEGIR also includes clinical researchers from Baylor College of Medicine/Texas Children’s Hospital; Icahn School of Medicine at Mount Sinai; Mayo Clinic; University of Arkansas; University of California; Rady Children’s Hospital; Lurie Children’s Hospital; Northwestern University; the National Institutes of Health; Tufts Medical Center, the University of Colorado at Denver; University of Illinois; University of Pennsylvania; University of North Carolina; University of Utah; Children’s Hospital of Philadelphia; and Bern University in Switzerland.

The network also will work with patient advocacy group including the American Partnership for Eosinophilic Disorders, the Campaign Urging Research for Eosinophilic Disease, and the Eosinophilic Family Coalition.

Read More at These Related links

CEGIR Website: www.rarediseasesnetwork.org/cms/CEGIR

Rare Diseases Clinical Research Network: www.rarediseasesnetwork.org

Rare Diseases Network Award Announcement: www.cincinnatichildrens.org/news/release/2019/rare-diseases-research-network

Rothenberg lab: www.cincinnatichildrens.org/research/divisions/a/allergy-immunology/labs/rothenberg/default/

Rothenberg lab Facebook page: www.facebook.com/RothenbergEosinophilicLab

Cincinnati Center for Eosinophilic Disorders: www.cchmc.org/cced

Cincinnati Center for Eosinophilic Disorders Facebook page: www.facebook.com/CCEDeos

About this blog

The Research Horizons blog features news and insights about the latest discoveries and innovations developed by the scientists of Cincinnati Children's. This blog does not provide medical advice, diagnosis, or treatment.